Larvol Delta - CA4948-102-Dose-Escalation-Expansion-Study-of-CA4948-as-Monotherapy-in-Patients-With-Acute-Myelogenous-Leukemia-AML-or-Myelodysplastic-Syndrome-MDS

Venclexta (venetoclax) - Roche, AbbVie

emavusertib (CA-4948) - Curis, Dr. Reddy’s

http://clinicaltrials.gov/ct2/show/NCT04278768

Mar 20, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next